P41-4 Transition of the style of cooperation between hospitals and clinics in the terminal care of lung cancer and its meaning

2021 ◽  
Vol 32 ◽  
pp. S352
Author(s):  
Kan Kato ◽  
Chikage Koganemaru ◽  
Kageaki Watanabe ◽  
Yukio Hosomi
Keyword(s):  
2019 ◽  
Vol 30 ◽  
pp. vi147
Author(s):  
Kan Kato ◽  
Chikage Koganemaru ◽  
Tokuken Oh ◽  
Kageaki Watanabe ◽  
Yuusuke Ookuma ◽  
...  

2018 ◽  
Vol 29 ◽  
pp. vii53
Author(s):  
Kan Kato ◽  
Chikage Koganemaru ◽  
Tokuken Oh ◽  
Kageaki Watanabe ◽  
Yuusuke Ookuma ◽  
...  

2017 ◽  
Vol 28 ◽  
pp. ix99
Author(s):  
Kan Kato ◽  
Maya Izawa ◽  
Eri Sato ◽  
Naoki Iwashita ◽  
Chikage Koganemaru ◽  
...  

2016 ◽  
Vol 27 ◽  
pp. vii102
Author(s):  
Kan Kato ◽  
Naoki Iwashita ◽  
Gou Matumoto ◽  
Maya Izawa ◽  
Eitetu Jyo ◽  
...  

1973 ◽  
Vol 49 (576) ◽  
pp. 732-736 ◽  
Author(s):  
R. G. Twycross
Keyword(s):  

BMJ Open ◽  
2021 ◽  
Vol 11 (4) ◽  
pp. e044969
Author(s):  
Adesola Oluwafunmilola Olumide ◽  
Amir Shmueli ◽  
Olayemi O Omotade ◽  
Emmanuel S Adebayo ◽  
Temitope O Alonge ◽  
...  

IntroductionWHO revealed that morbidity and mortality from non-communicable diseases (NCDs) are on the increase and NCDs accounted for approximately 29% of all deaths in Nigeria in 2016. This study was conducted to estimate the economic cost of selected NCDs—lung cancer, liver cancer and liver cirrhosis. These diseases are known to be associated with key modifiable health risk behaviours (smoking and alcohol use), which are prevalent in Nigeria and often commence during the adolescent years.MethodsData were obtained between 2016 and 2017, from mortality records of patients managed for the selected diseases in the University College Hospital, a major referral centre in Nigeria. Information on costs of treatment, clinic visits, admission and transportation was obtained. Average costs of terminal in-patient care and transportation costs (in 2020 prices) were computed per patient. Costs were converted to the US dollar equivalent using the current official rate of US$1: ₦360.50.ResultsTwenty-two (out of 90 cases recorded) could be retrieved and all the patients had been diagnosed in the terminal stages of the disease. The average direct costs were ₦510 152.62 (US$1415.13) for an average of 49.2 days of terminal care for lung cancer; ₦308 950.27 (US$857.00) and ₦238 121.83 (US$660.53) for an average of 16.6 and 21.7 days of terminal care for patients managed for liver cancer and liver cirrhosis, respectively.ConclusionThe economic costs of each of the diseases were very high. Findings emphasise the need for aggressive efforts to promote primary prevention, improve early diagnosis and provide affordable treatment in view of the fact that the monthly minimum wage is less than US$85.00 and treatment costs are borne out-of-pocket by the generality of the population in Nigeria.


JAMA ◽  
1966 ◽  
Vol 195 (6) ◽  
pp. 471-475 ◽  
Author(s):  
M. J. Krant

2016 ◽  
Vol 1 (13) ◽  
pp. 162-168
Author(s):  
Pippa Hales ◽  
Corinne Mossey-Gaston

Lung cancer is one of the most commonly diagnosed cancers across Northern America and Europe. Treatment options offered are dependent on the type of cancer, the location of the tumor, the staging, and the overall health of the person. When surgery for lung cancer is offered, difficulty swallowing is a potential complication that can have several influencing factors. Surgical interaction with the recurrent laryngeal nerve (RLN) can lead to unilateral vocal cord palsy, altering swallow function and safety. Understanding whether the RLN has been preserved, damaged, or sacrificed is integral to understanding the effect on the swallow and the subsequent treatment options available. There is also the risk of post-surgical reduction of physiological reserve, which can reduce the strength and function of the swallow in addition to any surgery specific complications. As lung cancer has a limited prognosis, the clinician must also factor in the palliative phase, as this can further increase the burden of an already compromised swallow. By understanding the surgery and the implications this may have for the swallow, there is the potential to reduce the impact of post-surgical complications and so improve quality of life (QOL) for people with lung cancer.


1994 ◽  
Vol 8 (3) ◽  
pp. 507-532 ◽  
Author(s):  
Gary M. Strauss ◽  
Arthur T. Skarin
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document